Advisory Alpha’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1,320
| Closed | -$209K | – | 437 |
|
2024
Q2 | $209K | Sell |
1,320
-1,370
| -51% | -$216K | 0.01% | 372 |
|
2024
Q1 | $348K | Hold |
2,690
| – | – | 0.01% | 271 |
|
2023
Q4 | $259K | Hold |
2,690
| – | – | 0.01% | 288 |
|
2023
Q3 | $326K | Hold |
2,690
| – | – | 0.02% | 228 |
|
2023
Q2 | $308K | Hold |
2,690
| – | – | 0.02% | 251 |
|
2023
Q1 | $371K | Hold |
2,690
| – | – | 0.02% | 207 |
|
2022
Q4 | $349K | Sell |
2,690
-185
| -6% | -$24K | 0.02% | 192 |
|
2022
Q3 | $318K | Hold |
2,875
| – | – | 0.02% | 196 |
|
2022
Q2 | $216K | Hold |
2,875
| – | – | 0.02% | 234 |
|
2022
Q1 | $225K | Sell |
2,875
-225
| -7% | -$17.6K | 0.01% | 246 |
|
2021
Q4 | $279K | Hold |
3,100
| – | – | 0.02% | 221 |
|
2021
Q3 | $287K | Sell |
3,100
-150
| -5% | -$13.9K | 0.02% | 210 |
|
2021
Q2 | $253K | Sell |
3,250
-140
| -4% | -$10.9K | 0.02% | 168 |
|
2021
Q1 | $253K | Sell |
3,390
-150
| -4% | -$11.2K | 0.03% | 153 |
|
2020
Q4 | $604K | Sell |
3,540
-20
| -0.6% | -$3.41K | 0.12% | 48 |
|
2020
Q3 | $519K | Hold |
3,560
| – | – | 0.11% | 46 |
|
2020
Q2 | $562K | Hold |
3,560
| – | – | 0.12% | 54 |
|
2020
Q1 | $411K | Hold |
3,560
| – | – | 0.12% | 58 |
|
2019
Q4 | $444K | Hold |
3,560
| – | – | 0.11% | 75 |
|
2019
Q3 | $288K | Hold |
3,560
| – | – | 0.09% | 87 |
|
2019
Q2 | $531K | Hold |
3,560
| – | – | 0.18% | 62 |
|
2019
Q1 | $423K | Hold |
3,560
| – | – | 0.15% | 65 |
|
2018
Q4 | $452K | Buy |
+3,560
| New | +$452K | 0.21% | 54 |
|